CYP1A2 activity can be evaluated using probe drugs, such as caffeine, where the rate of metabolism is indicative of enzyme activity. Additionally, genetic testing can identify polymorphisms in the CYP1A2 gene that may affect enzyme function. In vitro assays using liver microsomes or recombinant enzymes can also provide insights into CYP1A2 activity and its interaction with various compounds.
